Atrial Shunt Therapy for Heart Failure: An Update

Faculty and Program

	Suzanne Baron, MD, FSCAI Moderator		Vikrant Jagadeesan, MD, FSCAI Presenting Author
	William A. Gray, MD, FSCAI Paneslit		Sanjiv J. Shah, MD, FAHA, FASE Panelist

Acknowledgement of Commercial Support

This activity is supported by an unrestricted educational grant from Edwards Lifesciences.

Learning Objectives

Upon completion of this activity, participants will be able to:

Describe the evolving landscape of atrial shunt therapy in HF, including treatment developments that have shaped its management.
Evaluate key clinical trial data.
Identify opportunities to incorporate newer therapeutic options, including atrial shunt therapies, based on individual patient presentation.
Select the best treatment strategies to optimize outcomes for individuals with heart failure with multiple comorbidities.

Accredited Continuing Education Information

Accreditation Statement
The Society for Cardiovascular Angiography and Interventions (SCAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation
SCAI designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABIM MOC
Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn up to 0.5 MOC points in the American Board of Internal Medicine (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit learner completion information to ACCME for the purpose of granting ABIM MOC credit.

Successful Completion
Watch the content and complete the evaluation to obtain credit.

Summary


Availability:	On-Demand
	Access expires on 12/31/2026


Cost:	FREE


Credit Offered:	0.5 CME Credit 0.5 ABIM-MOC Point 0.5 Participation Credit